Evidence map›Paper›PMID 36045491›Full record

ArticleJournal of biomedical optics2022

Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 1: Raman spectroscopy fiber-optics system and in situ tissue characterization.

Fabien Picot, Roozbeh Shams, Frédérick Dallaire, Guillaume Sheehy, Tran Trang, David Grajales, Mirela Birlea, Dominique Trudel, Cynthia Ménard, Samuel Kadoury and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of biomedical optics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Journal of biomedical optics · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Fabien PicotPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada, Canada.
Roozbeh ShamsCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada, Canada.
Frédérick DallairePolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada, Canada.
Guillaume SheehyPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada, Canada.
Tran TrangPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada, Canada.
David GrajalesCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada, Canada.
Mirela BirleaCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada, Canada.
Dominique TrudelCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada, Canada.
Cynthia MénardCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada, Canada.
Samuel KadouryCentre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada, Canada.
Frédéric LeblondPolytechnique Montréal, Department of Engineering Physics, Montreal, Quebec, Canada, Canada.
Centre Hospitalier de l’Université de Montréal · CAPolytechnique Montréal · CA

Funding

CIHR
6 · The paper itself

Abstract

significanceThe diagnosis of prostate cancer (PCa) and focal treatment by brachytherapy are limited by the lack of precise intraoperative information to target tumors during biopsy collection and radiation seed placement. Image-guidance techniques could improve the safety and diagnostic yield of biopsy collection as well as increase the efficacy of radiotherapy.

aimTo estimate the accuracy of PCa detection using in situ Raman spectroscopy (RS) in a pilot in-human clinical study and assess biochemical differences between in vivo and ex vivo measurements. APPROACH: A new miniature RS fiber-optics system equipped with an electromagnetic (EM) tracker was guided by trans-rectal ultrasound-guided imaging, fused with preoperative magnetic resonance imaging to acquire 49 spectra in situ (in vivo) from 18 PCa patients. In addition, 179 spectra were acquired ex vivo in fresh prostate samples from 14 patients who underwent radical prostatectomy. Two machine-learning models were trained to discriminate cancer from normal prostate tissue from both in situ and ex vivo datasets.

resultsA support vector machine (SVM) model was trained on the in situ dataset and its performance was evaluated using leave-one-patient-out cross validation from 28 normal prostate measurements and 21 in-tumor measurements. The model performed at 86% sensitivity and 72% specificity. Similarly, an SVM model was trained with the ex vivo dataset from 152 normal prostate measurements and 27 tumor measurements showing reduced cancer detection performance mostly attributable to spatial registration inaccuracies between probe measurements and histology assessment. A qualitative comparison between in situ and ex vivo measurements demonstrated a one-to-one correspondence and similar ratios between the main Raman bands (e.g., amide I-II bands, phenylalanine).

conclusionsPCa detection can be achieved using RS and machine learning models for image-guidance applications using in situ measurements during prostate biopsy procedures.

Indexed as

ProstateProstatic NeoplasmsBiopsyHumansImage-Guided BiopsyMagnetic Resonance ImagingMaleProstatectomySpectrum Analysis, Ramanmachine learningmagnetic resonance imagingmultimodal imagingprostate cancerRaman spectroscopysupport vector machinestissue opticsultrasound imaging

Identifiers

PMID36045491
PMCPMC9433338
OpenAlexW4294128124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.